| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5607690 | IBSA | External anti-inflammatory and analgesic plaster preparation |
Apr, 2014
(10 years ago) | |
Flector is owned by Ibsa.
Flector contains Diclofenac Epolamine.
Flector has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Flector are:
- US5607690
Flector was authorised for market use on 31 January, 2007.
Flector is available in system;topical dosage forms.
The generics of Flector are possible to be released after 13 April, 2014.
Drugs and Companies using DICLOFENAC EPOLAMINE ingredient
Market Authorisation Date: 31 January, 2007
Treatment: NA
Dosage: SYSTEM;TOPICAL
How can I launch a generic of FLECTOR before it's drug patent expiration?
More Information on Dosage
FLECTOR family patents
